Zentalis Pharmaceuticals, Inc. — 4 Filings
213 4 filings on record
This page lists all 4 filings submitted to the SEC by Zentalis Pharmaceuticals, Inc. (ZNTL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Zentalis Pharmaceuticals, Inc. has filed 213 4 documents with the SEC since 2017. To view all SEC filings by Zentalis Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001725160-22-000048 | Feb 23, 2022 | Feb 22, 2022 |
| 4 | FORM 4 | 0001725160-22-000047 | Feb 23, 2022 | — |
| 4 | FORM 4 | 0001725160-22-000038 | Feb 15, 2022 | — |
| 4 | FORM 4 | 0001725160-22-000036 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000035 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000034 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000033 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000032 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000031 | Feb 14, 2022 | Feb 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000019 | Feb 7, 2022 | — |
| 4 | FORM 4 | 0001725160-22-000017 | Feb 3, 2022 | Feb 1, 2022 |
| 4 | FORM 4 | 0001725160-22-000015 | Jan 20, 2022 | Jan 18, 2022 |
| 4 | FORM 4 | 0001725160-22-000014 | Jan 20, 2022 | — |
| 4 | FORM 4 | 0001725160-22-000011 | Jan 19, 2022 | Jan 18, 2022 |
| 4 | FORM 4 | 0001725160-22-000009 | Jan 11, 2022 | Jan 10, 2022 |
| 4 | FORM 4 | 0001725160-22-000006 | Jan 5, 2022 | Jan 3, 2022 |
| 4 | FORM 4 | 0001725160-22-000005 | Jan 5, 2022 | Jan 3, 2022 |
| 4 | FORM 4 | 0001725160-22-000004 | Jan 5, 2022 | — |
| 4 | FORM 4 | 0001725160-21-000244 | Dec 21, 2021 | Dec 20, 2021 |
| 4 | FORM 4 | 0001725160-21-000240 | Dec 16, 2021 | Dec 15, 2021 |
| 4 | FORM 4 | 0001725160-21-000238 | Dec 13, 2021 | Dec 10, 2021 |
| 4 | FORM 4 | 0001725160-21-000235 | Dec 7, 2021 | Dec 6, 2021 |
| 4 | FORM 4 | 0001725160-21-000232 | Dec 2, 2021 | Dec 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000231 | Dec 2, 2021 | Dec 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000228 | Nov 23, 2021 | Nov 22, 2021 |
| 4 | FORM 4 | 0001725160-21-000224 | Nov 16, 2021 | Nov 15, 2021 |
| 4 | FORM 4 | 0001725160-21-000222 | Nov 12, 2021 | Nov 10, 2021 |
| 4 | FORM 4 | 0001725160-21-000213 | Nov 5, 2021 | — |
| 4 | FORM 4 | 0001725160-21-000211 | Nov 2, 2021 | Nov 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000210 | Nov 2, 2021 | Nov 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000207 | Oct 27, 2021 | Oct 25, 2021 |
| 4 | FORM 4 | 0001725160-21-000206 | Oct 27, 2021 | Oct 25, 2021 |
| 4 | FORM 4 | 0001725160-21-000201 | Oct 4, 2021 | Oct 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000200 | Oct 4, 2021 | Oct 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000199 | Oct 4, 2021 | Oct 2, 2021 |
| 4 | FORM 4 | 0001725160-21-000198 | Oct 4, 2021 | — |
| 4 | FORM 4 | 0001725160-21-000197 | Oct 4, 2021 | — |
| 4 | FORM 4 | 0001725160-21-000191 | Sep 2, 2021 | Sep 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000190 | Sep 2, 2021 | Sep 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000189 | Sep 2, 2021 | Sep 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000185 | Aug 20, 2021 | Aug 18, 2021 |
| 4 | FORM 4 | 0001725160-21-000176 | Aug 3, 2021 | Aug 2, 2021 |
| 4 | FORM 4 | 0001725160-21-000175 | Aug 3, 2021 | Aug 2, 2021 |
| 4 | FORM 4 | 0001725160-21-000174 | Aug 3, 2021 | Aug 2, 2021 |
| 4 | FORM 4 | 0001725160-21-000170 | Jul 8, 2021 | Jul 6, 2021 |
| 4 | FORM 4 | 0001725160-21-000169 | Jul 8, 2021 | Jul 6, 2021 |
| 4 | FORM 4 | 0001725160-21-000168 | Jul 8, 2021 | Jul 6, 2021 |
| 4 | FORM 4 | 0001725160-21-000164 | Jul 6, 2021 | Jul 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000163 | Jul 6, 2021 | Jul 1, 2021 |
| 4 | FORM 4 | 0001725160-21-000162 | Jul 6, 2021 | Jul 1, 2021 |